BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Hampton MB, Vick KA, Skoko JJ, Neumann CA. Peroxiredoxin Involvement in the Initiation and Progression of Human Cancer. Antioxid Redox Signal 2018;28:591-608. [PMID: 29237274 DOI: 10.1089/ars.2017.7422] [Cited by in Crossref: 33] [Cited by in F6Publishing: 34] [Article Influence: 8.3] [Reference Citation Analysis]
Number Citing Articles
1 Ding N, Jiang H, Thapa P, Hao Y, Alshahrani A, Allison D, Izumi T, Rangnekar VM, Liu X, Wei Q. Peroxiredoxin IV plays a critical role in cancer cell growth and radioresistance through the activation of the Akt/GSK3 signaling pathways. J Biol Chem 2022;:102123. [PMID: 35697073 DOI: 10.1016/j.jbc.2022.102123] [Reference Citation Analysis]
2 Zhang J, Li X, Zhao Z, Cai W, Fang J. Thioredoxin signaling pathways in cancer. Antioxid Redox Signal 2022. [PMID: 35686449 DOI: 10.1089/ars.2022.0074] [Reference Citation Analysis]
3 Huang Z, Zhang Z, Zhou C, Liu L, Huang C. Epithelial–mesenchymal transition: The history, regulatory mechanism, and cancer therapeutic opportunities. MedComm 2022;3. [DOI: 10.1002/mco2.144] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 3.0] [Reference Citation Analysis]
4 Xing F, Hu Q, Qin Y, Xu J, Zhang B, Yu X, Wang W. The Relationship of Redox With Hallmarks of Cancer: The Importance of Homeostasis and Context. Front Oncol 2022;12:862743. [DOI: 10.3389/fonc.2022.862743] [Cited by in Crossref: 2] [Article Influence: 2.0] [Reference Citation Analysis]
5 Carvalho LAC, Queijo RG, Baccaro ALB, Siena ÁDD, Silva WA, Rodrigues T, Maria-engler SS. Redox-Related Proteins in Melanoma Progression. Antioxidants 2022;11:438. [DOI: 10.3390/antiox11030438] [Reference Citation Analysis]
6 An Y, Jiang J, Zhou L, Shi J, Jin P, Li L, Peng L, He S, Zhang W, Huang C, Zou B, Xie N. Peroxiredoxin 1 is essential for natamycin-triggered apoptosis and protective autophagy in hepatocellular carcinoma. Cancer Lett 2021;521:210-23. [PMID: 34428517 DOI: 10.1016/j.canlet.2021.08.023] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 6.0] [Reference Citation Analysis]
7 Attaran S, Skoko JJ, Hopkins BL, Wright MK, Wood LE, Asan A, Woo HA, Feinberg A, Neumann CA. Peroxiredoxin-1 Tyr194 phosphorylation regulates LOX-dependent extracellular matrix remodelling in breast cancer. Br J Cancer 2021. [PMID: 34389806 DOI: 10.1038/s41416-021-01510-x] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
8 Zhang Y, Jiang J, Zhang J, Shen H, Wang M, Guo Z, Zang X, Shi H, Gao J, Cai H, Fang X, Qian H, Xu W, Zhang X. CircDIDO1 inhibits gastric cancer progression by encoding a novel DIDO1-529aa protein and regulating PRDX2 protein stability. Mol Cancer 2021;20:101. [PMID: 34384442 DOI: 10.1186/s12943-021-01390-y] [Cited by in F6Publishing: 18] [Reference Citation Analysis]
9 Andreadou I, Efentakis P, Frenis K, Daiber A, Schulz R. Thiol-based redox-active proteins as cardioprotective therapeutic agents in cardiovascular diseases. Basic Res Cardiol 2021;116:44. [PMID: 34275052 DOI: 10.1007/s00395-021-00885-5] [Cited by in F6Publishing: 7] [Reference Citation Analysis]
10 Shen Y, Xu H, Li L, Lu Y, Zhang M, Huang X, Tang X. Assessment of Potential Prognostic Value of Peroxiredoxin 1 in Oral Squamous Cell Carcinoma. Cancer Manag Res 2021;13:5725-37. [PMID: 34290530 DOI: 10.2147/CMAR.S319048] [Reference Citation Analysis]
11 Sun HN, Ren CX, Gong YX, Xie DP, Kwon T. Regulatory function of peroxiredoxin I on 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone-induced lung cancer development. Oncol Lett 2021;21:465. [PMID: 33907575 DOI: 10.3892/ol.2021.12726] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
12 Dahou H, Minati MA, Jacquemin P, Assi M. Genetic Inactivation of Peroxiredoxin-I Impairs the Growth of Human Pancreatic Cancer Cells. Antioxidants (Basel) 2021;10:570. [PMID: 33917763 DOI: 10.3390/antiox10040570] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
13 Xu M, Xu J, Zhu D, Su R, Zhuang B, Xu R, Li L, Chen S, Ling Y. Expression and prognostic roles of PRDXs gene family in hepatocellular carcinoma. J Transl Med 2021;19:126. [PMID: 33771165 DOI: 10.1186/s12967-021-02792-8] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
14 Jiao L, Wei J, Ye J, Zhang C. Prognostic Value of Peroxiredoxin-1 Expression in Patients with Solid Tumors: a Meta-Analysis of Cohort Study. Dis Markers 2021;2021:9508702. [PMID: 33747258 DOI: 10.1155/2021/9508702] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
15 Tan X, Banerjee P, Pham EA, Rutaganira FUN, Basu K, Bota-Rabassedas N, Guo HF, Grzeskowiak CL, Liu X, Yu J, Shi L, Peng DH, Rodriguez BL, Zhang J, Zheng V, Duose DY, Solis LM, Mino B, Raso MG, Behrens C, Wistuba II, Scott KL, Smith M, Nguyen K, Lam G, Choong I, Mazumdar A, Hill JL, Gibbons DL, Brown PH, Russell WK, Shokat K, Creighton CJ, Glenn JS, Kurie JM. PI4KIIIβ is a therapeutic target in chromosome 1q-amplified lung adenocarcinoma. Sci Transl Med 2020;12:eaax3772. [PMID: 31969487 DOI: 10.1126/scitranslmed.aax3772] [Cited by in Crossref: 14] [Cited by in F6Publishing: 14] [Article Influence: 14.0] [Reference Citation Analysis]
16 Ehrenfeld V, Heusel JR, Fulda S, van Wijk SJL. ATM inhibition enhances Auranofin-induced oxidative stress and cell death in lung cell lines. PLoS One 2020;15:e0244060. [PMID: 33338048 DOI: 10.1371/journal.pone.0244060] [Cited by in Crossref: 2] [Cited by in F6Publishing: 5] [Article Influence: 1.0] [Reference Citation Analysis]
17 Hayes JD, Dinkova-Kostova AT, Tew KD. Oxidative Stress in Cancer. Cancer Cell 2020;38:167-97. [PMID: 32649885 DOI: 10.1016/j.ccell.2020.06.001] [Cited by in Crossref: 140] [Cited by in F6Publishing: 367] [Article Influence: 70.0] [Reference Citation Analysis]
18 Pouliquen DL, Boissard A, Coqueret O, Guette C. Biomarkers of tumor invasiveness in proteomics (Review). Int J Oncol 2020;57:409-32. [PMID: 32468071 DOI: 10.3892/ijo.2020.5075] [Cited by in Crossref: 5] [Cited by in F6Publishing: 10] [Article Influence: 2.5] [Reference Citation Analysis]
19 Zhang X, Gao F, Li N, Zhang J, Dai L, Yang H. Peroxiredoxins and Immune Infiltrations in Colon Adenocarcinoma: Their Negative Correlations and Clinical Significances, an In Silico Analysis. J Cancer 2020;11:3124-43. [PMID: 32231717 DOI: 10.7150/jca.38057] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
20 Firczuk M, Bajor M, Graczyk-jarzynka A, Fidyt K, Goral A, Zagozdzon R. Harnessing altered oxidative metabolism in cancer by augmented prooxidant therapy. Cancer Letters 2020;471:1-11. [DOI: 10.1016/j.canlet.2019.11.037] [Cited by in Crossref: 11] [Cited by in F6Publishing: 13] [Article Influence: 5.5] [Reference Citation Analysis]
21 Ismail T, Kim Y, Lee H, Lee DS, Lee HS. Interplay Between Mitochondrial Peroxiredoxins and ROS in Cancer Development and Progression. Int J Mol Sci 2019;20:E4407. [PMID: 31500275 DOI: 10.3390/ijms20184407] [Cited by in Crossref: 22] [Cited by in F6Publishing: 38] [Article Influence: 7.3] [Reference Citation Analysis]
22 Tchouagué M, Grondin M, Glory A, Averill-bates D. Heat shock induces the cellular antioxidant defenses peroxiredoxin, glutathione and glucose 6-phosphate dehydrogenase through Nrf2. Chemico-Biological Interactions 2019;310:108717. [DOI: 10.1016/j.cbi.2019.06.030] [Cited by in Crossref: 13] [Cited by in F6Publishing: 19] [Article Influence: 4.3] [Reference Citation Analysis]
23 Jezierska-Drutel A, Attaran S, Hopkins BL, Skoko JJ, Rosenzweig SA, Neumann CA. The peroxidase PRDX1 inhibits the activated phenotype in mammary fibroblasts through regulating c-Jun N-terminal kinases. BMC Cancer 2019;19:812. [PMID: 31419957 DOI: 10.1186/s12885-019-6031-4] [Cited by in Crossref: 3] [Cited by in F6Publishing: 5] [Article Influence: 1.0] [Reference Citation Analysis]
24 Zhou X, Liang Z, Li K, Fang W, Tian Y, Luo X, Chen Y, Zhan Z, Zhang T, Liao S, Liu S, Liu Y, Fenical W, Tang L. Exploring the Natural Piericidins as Anti-Renal Cell Carcinoma Agents Targeting Peroxiredoxin 1. J Med Chem 2019;62:7058-69. [DOI: 10.1021/acs.jmedchem.9b00598] [Cited by in Crossref: 21] [Cited by in F6Publishing: 27] [Article Influence: 7.0] [Reference Citation Analysis]
25 Wang W, Shen X, Huang D, Jia W, Liu W, He Y. Peroxiredoxin 4 suppresses anoikis and augments growth and metastasis of hepatocellular carcinoma cells through the β-catenin/ID2 pathway. Cell Oncol 2019;42:769-81. [DOI: 10.1007/s13402-019-00460-0] [Cited by in Crossref: 4] [Cited by in F6Publishing: 7] [Article Influence: 1.3] [Reference Citation Analysis]
26 Kim Y, Jang HH. Role of Cytosolic 2-Cys Prx1 and Prx2 in Redox Signaling. Antioxidants (Basel) 2019;8:E169. [PMID: 31185618 DOI: 10.3390/antiox8060169] [Cited by in Crossref: 16] [Cited by in F6Publishing: 17] [Article Influence: 5.3] [Reference Citation Analysis]
27 Chawsheen HA, Jiang H, Ying Q, Ding N, Thapa P, Wei Q. The redox regulator sulfiredoxin forms a complex with thioredoxin domain-containing 5 protein in response to ER stress in lung cancer cells. J Biol Chem 2019;294:8991-9006. [PMID: 31000628 DOI: 10.1074/jbc.RA118.005804] [Cited by in Crossref: 5] [Cited by in F6Publishing: 9] [Article Influence: 1.7] [Reference Citation Analysis]
28 Skoko JJ, Attaran S, Neumann CA. Signals Getting Crossed in the Entanglement of Redox and Phosphorylation Pathways: Phosphorylation of Peroxiredoxin Proteins Sparks Cell Signaling. Antioxidants (Basel) 2019;8:E29. [PMID: 30678096 DOI: 10.3390/antiox8020029] [Cited by in Crossref: 12] [Cited by in F6Publishing: 10] [Article Influence: 4.0] [Reference Citation Analysis]
29 Sharapov MG, Novoselov VI, Gudkov SV. Radioprotective Role of Peroxiredoxin 6. Antioxidants (Basel) 2019;8:E15. [PMID: 30621289 DOI: 10.3390/antiox8010015] [Cited by in Crossref: 21] [Cited by in F6Publishing: 20] [Article Influence: 7.0] [Reference Citation Analysis]
30 Forshaw TE, Holmila R, Nelson KJ, Lewis JE, Kemp ML, Tsang AW, Poole LB, Lowther WT, Furdui CM. Peroxiredoxins in Cancer and Response to Radiation Therapies. Antioxidants (Basel) 2019;8:E11. [PMID: 30609657 DOI: 10.3390/antiox8010011] [Cited by in Crossref: 24] [Cited by in F6Publishing: 24] [Article Influence: 8.0] [Reference Citation Analysis]
31 Prata C, Facchini C, Leoncini E, Lenzi M, Maraldi T, Angeloni C, Zambonin L, Hrelia S, Fiorentini D. Sulforaphane Modulates AQP8-Linked Redox Signalling in Leukemia Cells. Oxid Med Cell Longev 2018;2018:4125297. [PMID: 30581529 DOI: 10.1155/2018/4125297] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 3.0] [Reference Citation Analysis]
32 Fischer J, Eglinton TW, Frizelle FA, Hampton MB. Peroxiredoxins in Colorectal Cancer: Predictive Biomarkers of Radiation Response and Therapeutic Targets to Increase Radiation Sensitivity? Antioxidants (Basel) 2018;7:E136. [PMID: 30301137 DOI: 10.3390/antiox7100136] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 0.5] [Reference Citation Analysis]
33 Bajor M, Zych AO, Graczyk-Jarzynka A, Muchowicz A, Firczuk M, Trzeciak L, Gaj P, Domagala A, Siernicka M, Zagozdzon A, Siedlecki P, Kniotek M, O'Leary PC, Golab J, Zagozdzon R. Targeting peroxiredoxin 1 impairs growth of breast cancer cells and potently sensitises these cells to prooxidant agents. Br J Cancer 2018;119:873-84. [PMID: 30287919 DOI: 10.1038/s41416-018-0263-y] [Cited by in Crossref: 18] [Cited by in F6Publishing: 26] [Article Influence: 4.5] [Reference Citation Analysis]
34 Li HX, Sun XY, Yang SM, Wang Q, Wang ZY. Peroxiredoxin 1 promoted tumor metastasis and angiogenesis in colorectal cancer. Pathol Res Pract 2018;214:655-60. [PMID: 29673884 DOI: 10.1016/j.prp.2018.03.026] [Cited by in Crossref: 13] [Cited by in F6Publishing: 17] [Article Influence: 3.3] [Reference Citation Analysis]